Page last updated: 2024-08-23

paroxetine and Complications, Pregnancy

paroxetine has been researched along with Complications, Pregnancy in 41 studies

Research

Studies (41)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (2.44)	18.2507
2000's	22 (53.66)	29.6817
2010's	15 (36.59)	24.3611
2020's	3 (7.32)	2.80

Authors

Authors	Studies
Aucott, L; Fitton, CA; Fleming, M; Mackay, DF; McLay, JS; Pell, JP; Steiner, MFC	1
Reimers, A; Reis, M; Svensson, M	1
Agius, M; Ripullone, K; Womersley, K	1
Bassi, M; Cauli, G; Gala, C; Iapichino, E; Marconi, AM; Quartieri Bollani, M; Rucci, P	1
Bonsel, GJ; Lambregtse-van den Berg, MP; Molenaar, NM	1
Hebert, MF; Hu, T; Wang, J; Zha, W	1
Blackwell, KA; Forray, A; Glover, J; Yonkers, KA	1
Bérard, A; Boukhris, T; Chaabane, S; Muanda, FT; Zhao, J	1
Jureidini, J; Mintzes, B	1
Bellantuono, C; Gentile, S	1
Einarson, A	4
Tanne, JH	1
Favrelière, S; Jaafari, N; Nourrisson, A; Pérault Pochat, MC	1
Bérard, A; Broy, P; Nakhai-Pour, HR	1
Antonioli, L; Blandizzi, C; Colucci, R; Corona, T; Fornai, M; Mantarro, S; Montagnani, S; Pergola, A; Ruggiero, E; Scollo, C; Testi, A; Tuccori, M	1
Aoun, J; Gorsane, MA; Krebs, MO; Soufia, M	1
Beste, J; Blackwell, JC; Patel, BN	1
Gilbert, AL; Grzeskowiak, LE; Morrison, JL	1
Bérard, A; De Vera, MA	1
Byatt, N; Deligiannidis, KM; Freeman, MP	1
Chilton, AP; Elias, E; Hubscher, SG; Milkiewicz, P	1
Chiu, CC; Huang, SY; Shen, WW; Su, KP	1
Altshuler, LL; Haynes, D; Hendrick, V; Hwang, S; Lee, E; Stowe, ZN	1
Newport, DJ; Stowe, ZN	1
Dahlem, P; Duijvestijn, YC; Kalmeijer, MD; Passier, AL; Smiers, F	1
Hallberg, P; Odlind, V; Sjöblom, V	1
Einarson, A; Koren, G	1
de Jong-van den Berg, L; Egberts, T; Kaasenbrood, H; Schobben, F; Ververs, T; Visser, G	1
Einarson, A; Wood, W	1
Ahmed, M; Parameshwaran, A; Swamy, P	1
de la Rosa M, A; De Las Cuevas, C; Sanz, EJ; Troyano, JM	1
Bar-Oz, B; Bérard, A; Boskovic, R; Einarson, A; Einarson, T; Koren, G; Malm, H; O'Brien, L	1
Bakker, MK; de Jong van den Berg, LT; de Walle, HE; Kölling, P; van den Berg, PB	1
Burbeck, R; McDonald, L; Pilling, S; Tomson, D	1
DeSantis, M; Einarson, A; Einarson, TR; Kennedy, D; Koren, G; Malm, H; Panchaud, A; Paulus, WD; Pistelli, A	1
Lamberg, L	1
Hostetter, A; Llewellyn, A; McLaughlin, E; Stowe, ZN; Strader, JR	1

Reviews

12 review(s) available for paroxetine and Complications, Pregnancy

Article	Year
In utero exposure to antidepressant medication and neonatal and child outcomes: a systematic review. Acta psychiatrica Scandinavica, 2020, Volume: 141, Issue:1 Topics: Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Conduct Disorder; Congenital Abnormalities; Depressive Disorder; Female; Gestational Age; Heart Defects, Congenital; Humans; Infant, Newborn; Neurodevelopmental Disorders; Paroxetine; Pregnancy; Pregnancy Complications; Premature Birth; Prenatal Exposure Delayed Effects; Risk Factors	2020
What are the risks associated with different Selective Serotonin Re-uptake Inhibitors (SSRIs) to treat depression and anxiety in pregnancy? An evaluation of current evidence. Psychiatria Danubina, 2017, Volume: 29, Issue:Suppl 3 Topics: Adult; Anxiety; Citalopram; Depression; Female; Humans; Paroxetine; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Serotonin	2017
Antidepressant use in pregnant and postpartum women. Annual review of clinical psychology, 2014, Volume: 10 Topics: Antidepressive Agents; Depression, Postpartum; Depressive Disorder; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Paroxetine; Persistent Fetal Circulation Syndrome; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects	2014
Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:3 Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Controlled Clinical Trials as Topic; Cross-Sectional Studies; Depressive Disorder; Female; Humans; Infant, Newborn; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Prospective Studies; Risk; Selective Serotonin Reuptake Inhibitors	2009
[Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn]. L'Encephale, 2010, Volume: 36 Suppl 2 Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Gestational Age; Humans; Infant, Newborn; Paroxetine; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Risk; Secondary Prevention; Selective Serotonin Reuptake Inhibitors	2010
Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update. Postgraduate medicine, 2010, Volume: 122, Issue:4 Topics: Abnormalities, Drug-Induced; Cardiovascular Abnormalities; Citalopram; Depression; Female; Fluoxetine; Fluvoxamine; Humans; Maternal-Fetal Exchange; Paroxetine; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Sertraline; Teratogens	2010
[SSRIs and pregnancy: a review of the literature]. L'Encephale, 2010, Volume: 36, Issue:6 Topics: Abnormalities, Drug-Induced; Antidepressive Agents; Depressive Disorder, Major; Drug-Related Side Effects and Adverse Reactions; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Infant, Newborn, Diseases; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Third; Risk Assessment; Selective Serotonin Reuptake Inhibitors	2010
Investigating outcomes following the use of selective serotonin reuptake inhibitors for treating depression in pregnancy: a focus on methodological issues. Drug safety, 2011, Nov-01, Volume: 34, Issue:11 Topics: Depressive Disorder; Female; Humans; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2011
Publishing statistically significant results with questionable clinical importance: focus on antidepressant use in pregnancy. The Journal of clinical psychiatry, 2012, Volume: 73, Issue:11 Topics: Abnormalities, Drug-Induced; Antidepressive Agents; Bias; Causality; Compensation and Redress; Cross-Sectional Studies; Data Interpretation, Statistical; Depressive Disorder; Drug Utilization; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Paroxetine; Preconception Care; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Product Surveillance, Postmarketing; Publishing; Risk Factors; Selective Serotonin Reuptake Inhibitors	2012
Antidepressant use in pregnancy: a critical review focused on risks and controversies. Acta psychiatrica Scandinavica, 2013, Volume: 127, Issue:2 Topics: Abnormalities, Drug-Induced; Antidepressive Agents; Depressive Disorder; Female; Humans; Infant, Newborn; Paroxetine; Persistent Fetal Circulation Syndrome; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Prenatal Exposure Delayed Effects; Risk Factors; Selective Serotonin Reuptake Inhibitors	2013
Clinical management of perinatal depression: focus on paroxetine. Psychopharmacology bulletin, 2003,Spring, Volume: 37 Suppl 1 Topics: Adult; Antidepressive Agents, Second-Generation; Depression, Postpartum; Female; Fetus; Humans; Infant, Newborn; Paroxetine; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors	2003
Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors. Clinical therapeutics, 2007, Volume: 29, Issue:5 Topics: Abnormalities, Drug-Induced; Adult; Amniocentesis; Antidepressive Agents, Second-Generation; Anxiety; Depression; Electrocardiography; Female; Humans; Infant, Newborn; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimesters; Ultrasonography	2007

Trials

1 trial(s) available for paroxetine and Complications, Pregnancy

Article	Year
Promoting the well-being of mothers with multidisciplinary psychosocial interventions in the perinatal period. Journal of affective disorders, 2019, 03-01, Volume: 246 Topics: Adult; Antidepressive Agents; Anxiety; Combined Modality Therapy; Depression; Depression, Postpartum; Female; Humans; Longitudinal Studies; Mothers; Paroxetine; Patient Acceptance of Health Care; Perinatal Care; Pregnancy; Pregnancy Complications; Psychotherapy; Risk Factors; Sertraline; Treatment Outcome	2019

Article

Year

Promoting the well-being of mothers with multidisciplinary psychosocial interventions in the perinatal period.

Journal of affective disorders, 2019, 03-01, Volume: 246

Topics: Adult; Antidepressive Agents; Anxiety; Combined Modality Therapy; Depression; Depression, Postpartum; Female; Humans; Longitudinal Studies; Mothers; Paroxetine; Patient Acceptance of Health Care; Perinatal Care; Pregnancy; Pregnancy Complications; Psychotherapy; Risk Factors; Sertraline; Treatment Outcome

2019

Other Studies

28 other study(ies) available for paroxetine and Complications, Pregnancy

Article	Year
[Pharmacokinetics of antidepressants during pregnancy]. Lakartidningen, 2020, 04-21, Volume: 117 Topics: Antidepressive Agents; Cytochrome P-450 CYP2D6; Female; Fluoxetine; Humans; Paroxetine; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors	2020
Dispensing patterns of selective serotonin reuptake inhibitors before, during and after pregnancy: a 16-year population-based cohort study from the Netherlands. Archives of women's mental health, 2020, Volume: 23, Issue:1 Topics: Adult; Antidepressive Agents; Cohort Studies; Drug Prescriptions; Female; Humans; Netherlands; Paroxetine; Peripartum Period; Population; Postpartum Period; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors	2020
Effect of Pregnancy on Paroxetine-Induced Adiposity and Glucose Intolerance in Mice. The Journal of pharmacology and experimental therapeutics, 2019, Volume: 371, Issue:1 Topics: Adiposity; Animals; Aromatase; Estradiol; Female; Glucose Intolerance; Hormone Replacement Therapy; Mice; Mice, Inbred C57BL; Obesity; Ovary; Paroxetine; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins	2019
Paroxetine use during pregnancy and the risk of cardiac defects. British journal of clinical pharmacology, 2016, Volume: 82, Issue:2 Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Female; Heart Defects, Congenital; Humans; Paroxetine; Pregnancy; Pregnancy Complications; Risk; Selective Serotonin Reuptake Inhibitors	2016
Should paroxetine be used to treat depression during pregnancy? The American journal of psychiatry, 2008, Volume: 165, Issue:11 Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug-Related Side Effects and Adverse Reactions; Evidence-Based Medicine; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Paroxetine; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic; Secondary Prevention; Substance Withdrawal Syndrome	2008
Influence of the media on women taking antidepressants during pregnancy. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:9 Topics: Adult; Adverse Drug Reaction Reporting Systems; Antidepressive Agents; Cardiovascular Abnormalities; Depressive Disorder; Drug Industry; Drug Information Services; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Internet; Mass Media; Paroxetine; Physician-Patient Relations; Pregnancy; Pregnancy Complications; Prevalence	2009
GlaxoSmithKline told to pay family $2.5m after jury finds paroxetine caused son's heart defects. BMJ (Clinical research ed.), 2009, Oct-15, Volume: 339 Topics: Antidepressive Agents, Second-Generation; Child, Preschool; Compensation and Redress; Depressive Disorder; Drug Industry; Female; Heart Defects, Congenital; Humans; Male; Paroxetine; Philadelphia; Pregnancy; Pregnancy Complications	2009
Use of antidepressants during pregnancy and the risk of spontaneous abortion. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2010, Jul-13, Volume: 182, Issue:10 Topics: Abortion, Spontaneous; Adolescent; Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Case-Control Studies; Confidence Intervals; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Gestational Age; Humans; Middle Aged; Odds Ratio; Paroxetine; Pregnancy; Pregnancy Complications; Quebec; Registries; Risk Factors; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Young Adult	2010
Paroxetine use in pregnancy and increased risk of heart defects: Evaluating the evidence. Canadian family physician Medecin de famille canadien, 2010, Volume: 56, Issue:8 Topics: Abnormalities, Drug-Induced; Adult; Depression; Evidence-Based Medicine; Female; Heart Defects, Congenital; Humans; Meta-Analysis as Topic; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Selective Serotonin Reuptake Inhibitors; Uncertainty	2010
Antidepressant use during pregnancy. FPIN’s clinical inquiries. American family physician, 2011, May-15, Volume: 83, Issue:10 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Evidence-Based Medicine; Female; Fluoxetine; Humans; Odds Ratio; Paroxetine; Physicians, Family; Pregnancy; Pregnancy Complications; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride	2011
Antidepressant use during pregnancy and the risk of pregnancy-induced hypertension. British journal of clinical pharmacology, 2012, Volume: 74, Issue:2 Topics: Adult; Antidepressive Agents; Case-Control Studies; Female; Humans; Hypertension, Pregnancy-Induced; Logistic Models; Multivariate Analysis; Odds Ratio; Paroxetine; Pregnancy; Pregnancy Complications; Prospective Studies; Quebec; Registries; Risk Assessment; Risk Factors; Selective Serotonin Reuptake Inhibitors; Young Adult	2012
Antidepressant induced cholestasis: hepatocellular redistribution of multidrug resistant protein (MRP2). Gut, 2003, Volume: 52, Issue:2 Topics: Acute Disease; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Biopsy; Cholestasis; Citalopram; Dothiepin; Female; Humans; Immunohistochemistry; Liver; Male; Middle Aged; Mitochondrial Proteins; Paroxetine; Pregnancy; Pregnancy Complications; Ribosomal Proteins; Saccharomyces cerevisiae Proteins	2003
Omega-3 fatty acids for depression in pregnancy. The American journal of psychiatry, 2003, Volume: 160, Issue:2 Topics: Adult; Depressive Disorder; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Female; Humans; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2003
Placental passage of antidepressant medications. The American journal of psychiatry, 2003, Volume: 160, Issue:5 Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fetal Blood; Fluoxetine; Humans; Maternal-Fetal Exchange; Paroxetine; Placenta; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Sertraline	2003
Neonatal intraventricular haemorrhage associated with maternal use of paroxetine. British journal of clinical pharmacology, 2003, Volume: 56, Issue:5 Topics: Cerebral Hemorrhage; Contraindications; Female; Humans; Infant, Newborn; Male; Paroxetine; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Selective Serotonin Reuptake Inhibitors	2003
Neonatal complications after intrauterine exposure to SSRI antidepressants. Prescrire international, 2004, Volume: 13, Issue:71 Topics: Antidepressive Agents; Citalopram; Depression; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; France; Humans; Infant, Newborn; Neonatal Abstinence Syndrome; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Third; Risk; Selective Serotonin Reuptake Inhibitors; Sertraline	2004
Abrupt discontinuation of psychotropic drugs following confirmation of pregnancy: a risky practice. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2005, Volume: 27, Issue:11 Topics: Adult; Antidepressive Agents, Second-Generation; Counseling; Depression, Postpartum; Female; Humans; Mental Disorders; Paroxetine; Pregnancy; Pregnancy Complications; Psychotropic Drugs; Risk Factors; Substance Withdrawal Syndrome; Teratogens	2005
Selective serotonin-reuptake inhibitors and persistent pulmonary hypertension of the newborn. The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20 Topics: Abnormalities, Drug-Induced; Confounding Factors, Epidemiologic; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Mental Disorders; Paroxetine; Persistent Fetal Circulation Syndrome; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors	2006
Counseling pregnant women treated with paroxetine. Concern about cardiac malformations. Canadian family physician Medecin de famille canadien, 2006, Volume: 52 Topics: Canada; Depressive Disorder; Female; Heart Defects, Congenital; Humans; Paroxetine; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications; Risk; Selective Serotonin Reuptake Inhibitors	2006
Prevalence and patterns of antidepressant drug use during pregnancy. European journal of clinical pharmacology, 2006, Volume: 62, Issue:10 Topics: Adolescent; Adult; Age Factors; Antidepressive Agents; Benzodiazepines; Databases, Factual; Depressive Disorder; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization Review; Female; Fluoxetine; Humans; Insurance, Pharmaceutical Services; Netherlands; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimesters; Prevalence; Time Factors	2006
Comment: paroxetine use during pregnancy: is it safe? The Annals of pharmacotherapy, 2006, Volume: 40, Issue:12 Topics: Depressive Disorder; Female; Humans; Paroxetine; Pregnancy; Pregnancy Complications	2006
Neonatal convulsions secondary to paroxetine withdrawal. JPMA. The Journal of the Pakistan Medical Association, 2007, Volume: 57, Issue:3 Topics: Antidepressive Agents, Second-Generation; Depression; Diagnosis, Differential; Epilepsy, Benign Neonatal; Female; Humans; Infant, Newborn; Male; Maternal Exposure; Neonatal Abstinence Syndrome; Paroxetine; Pregnancy; Pregnancy Complications	2007
Are psychotropics drugs used in pregnancy? Pharmacoepidemiology and drug safety, 2007, Volume: 16, Issue:9 Topics: Adolescent; Adult; Antidepressive Agents; Benzodiazepines; Cesarean Section; Depressive Disorder; Drug Utilization Review; Feeding and Eating Disorders; Female; Humans; Infant, Newborn; Lithium Compounds; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prospective Studies; Psychotropic Drugs; Spain; Surveys and Questionnaires; Treatment Outcome; Withholding Treatment	2007
Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands. British journal of clinical pharmacology, 2008, Volume: 65, Issue:4 Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Depressive Disorder; Female; Fetal Development; Humans; Male; Middle Aged; Netherlands; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimesters; Risk Assessment; Selective Serotonin Reuptake Inhibitors	2008
Antidepressants in the postpartum period: additional considerations. The American journal of psychiatry, 2008, Volume: 165, Issue:2 Topics: Antidepressive Agents; Breast Feeding; Depression, Postpartum; Female; Humans; Infant, Newborn; Paroxetine; Pregnancy; Pregnancy Complications; Psychotherapy; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Substance Withdrawal Syndrome	2008
Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. The American journal of psychiatry, 2008, Volume: 165, Issue:6 Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Female; Heart Defects, Congenital; Humans; Infant; Infant, Newborn; Odds Ratio; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Risk Assessment	2008
Safety of antidepressant use in pregnant and nursing women. JAMA, 1999, Jul-21, Volume: 282, Issue:3 Topics: Antidepressive Agents; Breast Feeding; Depression, Postpartum; Depressive Disorder; Female; Humans; Infant, Newborn; Lactation; Paroxetine; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Risk; Selective Serotonin Reuptake Inhibitors; Sleep	1999
Dose of selective serotonin uptake inhibitors across pregnancy: clinical implications. Depression and anxiety, 2000, Volume: 11, Issue:2 Topics: Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Humans; Infant, Newborn; Paroxetine; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2000